Feature: RF


RFID gateway. Any unit that deviates from its quality control record is immediately diverted into quarantine, eliminating the need for routine manual sampling and accelerating throughput. Each RFID read can be logged in a


centralised digital ledger, capturing the UDI, batch number and relevant QC data for every syringe. This comprehensive audit trail underpins compliance with Good Manufacturing Practice (GMP) standards, ISO 11040 guidelines, and regulations such as FDA 21 CFR 610.14 and the EU Falsified Medicines Directive. This pre-validation capability also enables


automated rejection of full batches where manufacturer-supplied QC data indicates systemic issues. As a result, manufacturers can benefit from fewer line stoppages and reduced rework, while real-time visibility into inventory status drives down material waste and yields significant cost savings.


Case Study 2: Monitoring excursion time Time out of Refrigeration (ToR) is the duration for which a temperature- sensitive product exceeds its prescribed cold-chain range, and is a critical metric for biologics, vaccines and specialty medications. In conventional workflows, a single batch-level temperature excursion often mandates the disposal of the entire lot. By contrast, Murata’s RFID tags allow


Figure 2: Murata’s RFID inlay, powered by coupling module technology


for unit-level ToR data to be recorded with every scan. Should a syringe exceed its allowable ToR threshold, only that unit is flagged and removed, while compliant items continue through the process. This precision can significantly reduce physical and monetary waste, preserving supplies for urgent clinical needs. With high- value products, this can translate into substantial cost avoidance at the pallet level. Moreover, aggregated ToR logs can become a diagnostic resource, enabling quality teams to analyse excursion


patterns, identify handling or storage inefficiencies, and implement targeted corrective actions, whether by refining standard operating procedures or upgrading refrigeration equipment.


Case Study 3: Aftermarket applications Murata’s solution also has the potential to extend beyond the production of primary and secondary containers into connected device and aftermarket ecosystems. In smart, rechargeable insulin injectors, for example, embedded RFID tags can relay usage data to cloud platforms, enabling real-time patient monitoring and adherence tracking. Similarly, the same tags can store links to digital instructions or batch specific documentation, bolstering counterfeit prevention and enhancing end user confidence. By uniting hardware miniaturisation,


advanced RF design and seamless data integration, Murata’s RFID technology is designed to provide medical professionals with a level of traceability and operational efficiency that was previously unattainable.


Data-driven healthcare As healthcare systems seek to balance efficiency, safety and sustainability, serialisation technologies are becoming indispensable. Murata’s embedded RFID solutions are designed to directly address the limitations of conventional barcode and QR systems, enabling unit- level traceability that scales across global manufacturing and supply chains. Moreover, the integration of Murata’s


Figure 3: Murata's tags, unlike traditional RFID technology, eliminate blind spots


RFID into syringe components supports automation, reduces human error, and opens new frontiers in smart device connectivity and aſtermarket applications, especially as personalised medicine and biologics continue to grow. By providing pharmaceutical stakeholders with instant access to product-level data, from production through inspection, storage and administration, RFID technology helps medical professionals to mitigate costly inefficiencies and enhance patient safety.


www.electronicsworld.co.uk October 2025 35


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44